SIMG
CLB icon

Stephens Investment Management Group’s Core Laboratories CLB Stock Holding History

Stephens Investment Management Group’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-467,652
Closed -$17.6M – 162
2019
Q4 		$17.6M Sell
467,652
-2,549
-0.5% -$115K 0.33% 105
2019
Q3 		$21.9M Buy
470,201
+228,526
+95% +$10.6M 0.44% 92
2019
Q2 		$12.6M Buy
241,675
+3,330
+1% +$195K 0.24% 120
2019
Q1 		$16.4M Buy
238,345
+1,437
+0.6% +$96.3K 0.33% 110
2018
Q4 		$14.1M Sell
236,908
-4,523
-2% -$390K 0.34% 108
2018
Q3 		$28M Buy
241,431
+4,908
+2% +$554K 0.52% 87
2018
Q2 		$29.7M Sell
236,523
-4,857
-2% -$591K 0.6% 79
2018
Q1 		$26.1M Sell
241,380
-744
-0.3% -$82.3K 0.57% 83
2017
Q4 		$26.5M Buy
242,124
+4,795
+2% +$479K 0.61% 74
2017
Q3 		$23.4M Sell
237,329
-567
-0.2% -$55K 0.54% 81
2017
Q2 		$24.1M Sell
237,896
-257
-0.1% -$27.7K 0.58% 76
2017
Q1 		$27.5M Buy
238,153
+23,713
+11% +$2.76M 0.68% 66
2016
Q4 		$25.7M Buy
214,440
+13,130
+7% +$1.45M 0.72% 60
2016
Q3 		$22.6M Buy
201,310
+16,340
+9% +$1.88M 0.67% 68
2016
Q2 		$22.9M Buy
184,970
+215
+0.1% +$26K 0.75% 49
2016
Q1 		$20.8M Buy
184,755
+13,625
+8% +$1.42M 0.73% 60
2015
Q4 		$18.6M Sell
171,130
-2,325
-1% -$266K 0.66% 63
2015
Q3 		$17.3M Buy
173,455
+92,930
+115% +$10.1M 0.61% 70
2015
Q2 		$9.18M Buy
80,525
+375
+0.5% +$45.5K 0.27% 129
2015
Q1 		$8.38M Sell
80,150
-1,130
-1% -$120K 0.25% 135
2014
Q4 		$9.78M Sell
81,280
-655
-0.8% -$86K 0.29% 125
2014
Q3 		$12M Buy
81,935
+16,690
+26% +$2.58M 0.36% 112
2014
Q2 		$10.9M Sell
65,245
-500
-0.8% -$89K 0.34% 115
2014
Q1 		$13M Buy
65,745
+15,550
+31% +$2.94M 0.4% 99
2013
Q4 		$9.59M Buy
50,195
+17,860
+55% +$3.32M 0.32% 120
2013
Q3 		$5.47M Buy
32,335
+19,760
+157% +$3.07M 0.19% 129
2013
Q2 		$1.91M Buy
+12,575
New +$1.78M 0.11% 123

Other funds holding CLB

VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Stephens Investment Management Group's CLB Position: Q1 2020 in Review

Stephens Investment Management Group sold out of Core Laboratories (CLB) in Q1 2020, closing a stake of 467,652 shares — an estimated $17.6M sold.

Stephens Investment Management Group first reported a position in CLB in Q2 2013 and held it in 27 quarters. The position peaked at $29.7M in Q2 2018. 207 funds tracked by Wall St. Rank hold CLB as of Q1 2020.

  • Stephens Investment Management Group reported no remaining Core Laboratories position as of Q1 2020 after selling out during the quarter.
  • Stephens Investment Management Group sold 467,652 Core Laboratories shares in Q1 2020, an estimated $17.6M.
  • Stephens Investment Management Group first reported a position in Core Laboratories in Q2 2013 and held it in 27 quarters.
  • Stephens Investment Management Group's Core Laboratories position peaked at $29.7M in Q2 2018.
  • 207 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2020.

Based on Stephens Investment Management Group's 13F filing for Q1 2020, filed 14 May 2020.